Randomized Controlled Clinical Trial of Cognitive Behavioral Therapy for Complicated Grief

Ludwig-Maximilians - University of Munich1 site in 1 country51 target enrollmentMay 2005

ConditionsGrief

Overview

Phase: N/A
Intervention: Not specified
Conditions: Grief
Sponsor: Ludwig-Maximilians - University of Munich
Enrollment: 51
Locations: 1
Primary Endpoint: PG-13 (Prolonged Grief Interview - 13 Item version)
Status: Completed
Last Updated: 10 years ago

Overview Investigators Eligibility Criteria Outcomes Sites Similar Trials

Overview

Brief Summary

The purpose of this study is to determine whether cognitive behavioral therapy (CG-CBT) for complicated grief is superior to wait list condition in patients with comorbid complicated grief. To evaluate the effect pre-post changes for patients in the CG-CBT-group will be compared to changes in the wait list group.

Registry

clinicaltrials.gov

Start Date

May 2005

End Date

February 2011

Last Updated

10 years ago

Study Type

Interventional

Study Design

Factorial

Sex

All

Investigators

Sponsor

Ludwig-Maximilians - University of Munich

Responsible Party

Principal Investigator

Rita Rosner

Prof. Dr. Rita Rosner

Ludwig-Maximilians - University of Munich

Eligibility Criteria

Inclusion Criteria

•age complicated grief diagnosis

Exclusion Criteria

•acute suicidality

Outcomes

Primary Outcomes

PG-13 (Prolonged Grief Interview - 13 Item version)

Time Frame: Change between intake (t1) and end of treatment (t2) in complicated grief severity within 5 months. t1= before treatment or wait list begins, t2 = 4 months after t1 (end of treatment, end of waitlist), t3 = follow-up (1.5 years after t2)

Secondary Outcomes

Comorbid Diagnoses by DIA-X-Interview(Change between intake (t1) and end of treatment (t2) in number of comorbid psychiatric diagnoses within 5 months; t1= before treatment or wait list begins, t2 = 4 months after t1 (end of treatment, end of waitlist), t3 = follow-up (1.5 years after t2))
Symptom Checklist 90 revised (SCL-90R; Subscale General Symptom Index, GSI)(Change between intake (t1) and end of treatment (t2) in general distress symptoms within 5 months. t1= before treatment or wait list begins, t2 = 4 months after t1 (end of treatment, end of waitlist), t3 = follow-up (1.5 years after t2))